West Pharmaceutical Services Gross Profit 2010-2024 | WST

West Pharmaceutical Services annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • West Pharmaceutical Services gross profit for the quarter ending March 31, 2024 was $0.230B, a 15.15% decline year-over-year.
  • West Pharmaceutical Services gross profit for the twelve months ending March 31, 2024 was $1.088B, a 3.1% decline year-over-year.
  • West Pharmaceutical Services annual gross profit for 2023 was $1.129B, a 0.62% decline from 2022.
  • West Pharmaceutical Services annual gross profit for 2022 was $1.136B, a 3.37% decline from 2021.
  • West Pharmaceutical Services annual gross profit for 2021 was $1.176B, a 53.14% increase from 2020.
West Pharmaceutical Services Annual Gross Profit
(Millions of US $)
2023 $1,129
2022 $1,136
2021 $1,176
2020 $768
2019 $606
2018 $545
2017 $513
2016 $501
2015 $456
2014 $448
2013 $435
2012 $388
2011 $339
2010 $318
2009 $304
West Pharmaceutical Services Quarterly Gross Profit
(Millions of US $)
2024-03-31 $230
2023-12-31 $278
2023-09-30 $288
2023-06-30 $291
2023-03-31 $271
2022-12-31 $262
2022-09-30 $268
2022-06-30 $322
2022-03-31 $285
2021-12-31 $301
2021-09-30 $288
2021-06-30 $315
2021-03-31 $272
2020-12-31 $211
2020-09-30 $195
2020-06-30 $195
2020-03-31 $167
2019-12-31 $153
2019-09-30 $148
2019-06-30 $158
2019-03-31 $147
2018-12-31 $133
2018-09-30 $136
2018-06-30 $142
2018-03-31 $134
2017-12-31 $129
2017-09-30 $125
2017-06-30 $125
2017-03-31 $134
2016-12-31 $124
2016-09-30 $121
2016-06-30 $133
2016-03-31 $123
2015-12-31 $120
2015-09-30 $108
2015-06-30 $118
2015-03-31 $110
2014-12-31 $110
2014-09-30 $110
2014-06-30 $122
2014-03-31 $106
2013-12-31 $107
2013-09-30 $106
2013-06-30 $111
2013-03-31 $112
2012-12-31 $98
2012-09-30 $90
2012-06-30 $99
2012-03-31 $101
2011-12-31 $85
2011-09-30 $81
2011-06-30 $85
2011-03-31 $88
2010-12-31 $78
2010-09-30 $75
2010-06-30 $83
2010-03-31 $82
2009-12-31 $84
2009-09-30 $72
2009-06-30 $79
2009-03-31 $69
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.159B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00